Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient mice
Authors:
- 1 July 2018
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 830, 76-86
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation of China (81770446)
- Six Talents Peak Project of Jiangsu Province (SWYY-022)
- Nantong University Cooperative Innovation Program of Small Molecular Compound R&D
This publication has 42 references indexed in Scilit:
- Endogenous Bioactive Peptides as Potential Biomarkers for Atherosclerotic Coronary Heart DiseaseSensors, 2012
- Enhanced expression of salusin-β contributes to progression of atherosclerosis in LDL receptor deficient miceCanadian Journal of Physiology and Pharmacology, 2012
- The roles of salusins in atherosclerosis and related cardiovascular diseasesJournal of the American Society of Hypertension, 2011
- JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery diseaseWorld Journal of Gastroenterology, 2011
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2010
- Chronic infusion of salusin-α and -β exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient miceAtherosclerosis, 2010
- Genetic control ofde novolipogenesis: role in diet-induced obesityCritical Reviews in Biochemistry and Molecular Biology, 2010
- Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE−/−miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†Hepatology, 2008
- Impact of Salusin-α and -β on Human Macrophage Foam Cell Formation and Coronary AtherosclerosisCirculation, 2008